semaglutide flow study 🔴Cardiovascular outcomes with by severity of chronic kidney disease in type 2 diabetes: the trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Brendon Neuen on X: "Johannes

Maroon, MD, FACS is clinical professor and vice chairman of the Department of Neurological Surgery and Heindl Scholar in Neuroscience at the University of Pittsburgh Medical Center

Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes

DyLight488 Conjugated Goat Anti-Rabbit IgG (BA1127) and Cy3 Conjugated Goat Anti-Mouse IgG (BA1031) were used as secondary antibody at 1:100 dilution and incubated for 30 minutes at 37C

Together, lets embark on a journey toward optimal wellness, embracing the power of science-backed supplements while prioritizing transparency and quality

Pharmacovigilance-based drug repurposing: the search for inverse signals via openvigil identifies putative drugs against viral respiratory infections